NO20033634D0 - GLYT-1 inhibitorer - Google Patents

GLYT-1 inhibitorer

Info

Publication number: NO20033634D0
Authority: NO; Norway
Prior art keywords: glyt; inhibitors; neurological; pharmaceutical; compound
Prior art date: 2001-02-16

Application number

NO20033634A

Other languages

English (en)

Other versions

NO329038B1 (no

NO20033634L (no

Inventor

Ian Egle

William Delaney

Zhaoqing Wang

Richard Shumacher

Allen T Hopper

Ashok Tehim

Shawn Maddarod

Original Assignee

Nps Allelix Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-16

Filing date

2003-08-15

Publication date

2003-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23026417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20033634(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-08-15 Application filed by Nps Allelix Corp filed Critical Nps Allelix Corp

2003-08-15 Publication of NO20033634D0 publication Critical patent/NO20033634D0/no

2003-10-08 Publication of NO20033634L publication Critical patent/NO20033634L/no

2010-08-02 Publication of NO329038B1 publication Critical patent/NO329038B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Epoxy Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

NO20033634A 2001-02-16 2003-08-15 Forbindelser med GLyT-1-transport inhiberende aktivitet, farmasoytisk preparat, anvendelse samt fremgangsmate for fremstilling NO329038B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US26924101P	2001-02-16	2001-02-16
PCT/CA2002/000176 WO2002066456A2 (en)	2001-02-16	2002-02-15	Thiophene substituted amine derivatives as glyt-1 inhibitors

Publications (3)

Publication Number	Publication Date
NO20033634D0 true NO20033634D0 (no)	2003-08-15
NO20033634L NO20033634L (no)	2003-10-08
NO329038B1 NO329038B1 (no)	2010-08-02

Family

ID=23026417

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033634A NO329038B1 (no)	2001-02-16	2003-08-15	Forbindelser med GLyT-1-transport inhiberende aktivitet, farmasoytisk preparat, anvendelse samt fremgangsmate for fremstilling

Country Status (30)

Country	Link
US (1)	US6667336B2 (no)
EP (1)	EP1368336B9 (no)
JP (2)	JP2004523548A (no)
KR (1)	KR100900020B1 (no)
CN (1)	CN1219776C (no)
AT (1)	ATE327986T1 (no)
AU (1)	AU2002235682C1 (no)
BG (1)	BG108164A (no)
BR (1)	BR0207307A (no)
CA (1)	CA2438367A1 (no)
CY (1)	CY1105529T1 (no)
CZ (1)	CZ20032503A3 (no)
DE (1)	DE60211866T2 (no)
DK (1)	DK1368336T3 (no)
EA (1)	EA006636B1 (no)
EE (1)	EE05329B1 (no)
ES (1)	ES2266446T3 (no)
HR (1)	HRP20030696A2 (no)
HU (1)	HUP0303185A3 (no)
IL (1)	IL157194A (no)
MX (1)	MXPA03007309A (no)
NO (1)	NO329038B1 (no)
NZ (1)	NZ527695A (no)
PL (1)	PL365024A1 (no)
PT (1)	PT1368336E (no)
SI (1)	SI1368336T1 (no)
SK (1)	SK287304B6 (no)
UA (1)	UA75114C2 (no)
WO (1)	WO2002066456A2 (no)
ZA (1)	ZA200307201B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6191165B1 (en) *	1996-05-31	2001-02-20	Allelix Neuroscience Inc.	Pharmaceutical for treatment of neurological and neuropsychiatric disorders
SI1830833T1 (sl) *	2004-12-16	2010-05-31	Janssen Pharmaceutica Nv	Kombinacija inhibitorja glicinskega transporterja GlyT in antipsihotika za zdravljenje simptomovshizofrenije in tudi njena priprava in njena uporaba
WO2008040669A2 (en) *	2006-10-02	2008-04-10	Janssen Pharmaceutica N.V.	Novel intermediates for the preparation of a glyt1 inhibitor
WO2008065500A2 (en) *	2006-11-30	2008-06-05	Pfizer Products Inc.	Heteroaryl amides as type i glycine transport inhibitors
CN103374057B (zh) *	2012-04-16	2015-08-19	中国医药集团总公司四川抗菌素工业研究所	一种对甘氨酸转运子具有抑制活性的化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3010599A1 (de)	1979-03-22	1980-10-09	Continental Pharma	Derivate von glycinamid, deren herstellung und verwendung
BE885303A (fr)	1980-09-19	1981-03-19	Continental Pharma	Glycinamides
US4383999A (en)	1981-05-26	1983-05-17	Smithkline Beckman Corporation	Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
AU552050B2 (en)	1981-05-26	1986-05-22	Smithkline Beckman Corporation	N-substituted azeheterocyclic carboxylic acids and their esters
US4514414A (en)	1982-10-25	1985-04-30	Smithkline Beckman Corporation	N-Substituted pyrrolidineacetic acids and their esters
DK288385D0 (da)	1985-06-26	1985-06-26	Novo Industri As	Aminosyrederivater
FI864246A7 (fi)	1985-11-08	1987-05-09	Warner Lambert Co	N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4772615A (en)	1985-11-08	1988-09-20	Warner-Lambert Company	Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
ES2059360T3 (es)	1986-01-07	1994-11-16	Novo Nordisk As	Nuevos derivados de aminoacidos.
JPH02129158A (ja)	1988-11-07	1990-05-17	Nippon Steel Corp	光学活性なグリシン誘導体及びその製造方法
IE913279A1 (en) *	1990-09-26	1992-04-08	Astra Ab	(2-Thienyl)alkylamine Derivatives Having Neuroprotective¹Properties
ES2036926B1 (es)	1991-08-08	1994-01-16	Uriach & Cia Sa J	"procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
WO1997020553A1 (en)	1995-12-07	1997-06-12	Javitt Daniel C	Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists
US6191165B1 (en)	1996-05-31	2001-02-20	Allelix Neuroscience Inc.	Pharmaceutical for treatment of neurological and neuropsychiatric disorders
HUP0100815A3 (en) *	1996-05-31	2002-11-28	Allelix Neuroscience Inc South	Pharmaceutical for treatment of neurological and neuropsychiatric disorders
ATE304528T1 (de) *	1996-07-22	2005-09-15	Novo Nordisk As	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
HUP0101300A3 (en) *	1998-01-09	2002-11-28	Pfizer	Matrix metalloprotease inhibitors
US6103743A (en) *	1999-08-06	2000-08-15	Allelix Neuroscience, Inc.	Unsaturated amino acid derivatives

2002
- 2002-02-15 CA CA002438367A patent/CA2438367A1/en not_active Abandoned
- 2002-02-15 HR HR20030696A patent/HRP20030696A2/xx not_active Application Discontinuation
- 2002-02-15 DE DE60211866T patent/DE60211866T2/de not_active Expired - Lifetime
- 2002-02-15 PL PL02365024A patent/PL365024A1/xx unknown
- 2002-02-15 AT AT02702186T patent/ATE327986T1/de not_active IP Right Cessation
- 2002-02-15 CN CNB028050819A patent/CN1219776C/zh not_active Expired - Fee Related
- 2002-02-15 EE EEP200300394A patent/EE05329B1/xx not_active IP Right Cessation
- 2002-02-15 NZ NZ527695A patent/NZ527695A/en unknown
- 2002-02-15 ES ES02702186T patent/ES2266446T3/es not_active Expired - Lifetime
- 2002-02-15 MX MXPA03007309A patent/MXPA03007309A/es active IP Right Grant
- 2002-02-15 BR BR0207307-2A patent/BR0207307A/pt not_active IP Right Cessation
- 2002-02-15 US US10/077,579 patent/US6667336B2/en not_active Expired - Fee Related
- 2002-02-15 AU AU2002235682A patent/AU2002235682C1/en not_active Ceased
- 2002-02-15 PT PT02702186T patent/PT1368336E/pt unknown
- 2002-02-15 HU HU0303185A patent/HUP0303185A3/hu unknown
- 2002-02-15 JP JP2002565971A patent/JP2004523548A/ja active Pending
- 2002-02-15 SI SI200230381T patent/SI1368336T1/sl unknown
- 2002-02-15 EA EA200300900A patent/EA006636B1/ru not_active IP Right Cessation
- 2002-02-15 EP EP02702186A patent/EP1368336B9/en not_active Expired - Lifetime
- 2002-02-15 DK DK02702186T patent/DK1368336T3/da active
- 2002-02-15 KR KR1020037010609A patent/KR100900020B1/ko not_active Expired - Fee Related
- 2002-02-15 CZ CZ20032503A patent/CZ20032503A3/cs unknown
- 2002-02-15 WO PCT/CA2002/000176 patent/WO2002066456A2/en not_active Ceased
- 2002-02-15 UA UA2003087630A patent/UA75114C2/uk unknown
- 2002-02-15 SK SK1144-2003A patent/SK287304B6/sk not_active IP Right Cessation
2003
- 2003-07-31 IL IL157194A patent/IL157194A/en not_active IP Right Cessation
- 2003-08-15 NO NO20033634A patent/NO329038B1/no not_active IP Right Cessation
- 2003-09-09 BG BG108164A patent/BG108164A/xx unknown
- 2003-09-15 ZA ZA200307201A patent/ZA200307201B/en unknown
2006
- 2006-08-22 CY CY20061101160T patent/CY1105529T1/el unknown
2009
- 2009-11-09 JP JP2009255663A patent/JP2010059182A/ja active Pending

Also Published As

Publication number	Publication date
NZ527695A (en)	2005-05-27
HUP0303185A3 (en)	2008-12-29
CN1219776C (zh)	2005-09-21
PT1368336E (pt)	2006-10-31
DK1368336T3 (da)	2006-10-02
EA006636B1 (ru)	2006-02-24
BG108164A (en)	2004-07-30
CZ20032503A3 (cs)	2004-02-18
AU2002235682C1 (en)	2008-12-11
ES2266446T3 (es)	2007-03-01
KR100900020B1 (ko)	2009-06-01
IL157194A (en)	2006-12-31
HRP20030696A2 (en)	2005-04-30
SI1368336T1 (sl)	2006-10-31
JP2010059182A (ja)	2010-03-18
EE200300394A (et)	2003-12-15
NO329038B1 (no)	2010-08-02
EE05329B1 (et)	2010-08-16
EP1368336B1 (en)	2006-05-31
UA75114C2 (en)	2006-03-15
BR0207307A (pt)	2004-08-17
EP1368336B9 (en)	2007-02-14
ZA200307201B (en)	2004-07-28
ATE327986T1 (de)	2006-06-15
DE60211866T2 (de)	2007-06-14
HK1061025A1 (en)	2004-09-03
MXPA03007309A (es)	2004-06-30
NO20033634L (no)	2003-10-08
AU2002235682B2 (en)	2007-04-26
PL365024A1 (en)	2004-12-27
KR20040028719A (ko)	2004-04-03
CY1105529T1 (el)	2010-07-28
US20030176489A1 (en)	2003-09-18
EA200300900A1 (ru)	2004-02-26
WO2002066456A3 (en)	2002-10-17
US6667336B2 (en)	2003-12-23
CN1491221A (zh)	2004-04-21
DE60211866D1 (de)	2006-07-06
EP1368336A2 (en)	2003-12-10
CA2438367A1 (en)	2002-08-29
SK11442003A3 (sk)	2004-03-02
HUP0303185A2 (hu)	2003-12-29
SK287304B6 (sk)	2010-06-07
JP2004523548A (ja)	2004-08-05
WO2002066456A2 (en)	2002-08-29

Publication	Publication Date	Title
NO985711D0 (no)	1998-12-07	Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
ATE440603T1 (de)	2009-09-15	8-hydroxychinolinderivate
ATE371656T1 (de)	2007-09-15	Heteroaryl-pyrimidinderivate als jak-inhibitoren
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
PT1411926E (pt)	2005-10-31	Inibidores de integrina para o tratamento de doencas oftalmicas
IS6087A (is)	2001-09-26	N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
DE69917005D1 (de)	2004-06-09	Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
NO20033634D0 (no)	2003-08-15	GLYT-1 inhibitorer
MXPA05014143A (es)	2006-02-24	Derivados de cumarina para el tratamiento de trastornos oftalmicos.
SE0004827D0 (sv)	2000-12-22	Therapeutic compounds
TNSN99158A1 (ar)	2005-11-10	طريقة لمنع الاصابة بالربو
ZA200503703B (en)	2006-10-25	Use of levocetirizine for the treatment of persistent allergic rhinitis
SE0100295D0 (sv)	2001-02-01	New compounds
ZA200400824B (en)	2004-07-20	Pyridin-2-yl-methlyamine derivatives for treating opioid dependence.
WO2004035031A3 (en)	2004-07-15	Treatment of uveal melanoma
MXPA04005310A (es)	2004-09-13	Inhibidores de fosfolipasa a2 citosolica.

Legal Events

Date	Code	Title	Description
2008-09-01	CREP	Change of representative	Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO
2011-09-26	MM1K	Lapsed by not paying the annual fees